Can Curi Bio’s Curiverse solve the scalability problem in human-relevant drug discovery?
Human-relevant drug screening is hitting a scale problem. Curi Bio’s Curiverse aims to turn 3D tissue models into industrial workflows.
Pharma & Biotech
Medical Devices & Diagnostics
Curi Bio and Battelle commercialise human NMJ assay as GLP-ready alternative to mouse bioassay for botulinum toxin testing
Curi Bio and Battelle partner to commercialise a human NMJ assay for botulinum toxin potency testing. What this changes for NAM adoption and the mouse bioassay. Read more.